ONCO
Onconetix, Inc.
Price Chart
Latest Quote
$0.95
+0.01 (+0.53%)
Current Price
| Previous Close | $0.94 |
| Open | $0.89 |
| Day High | $0.95 |
| Day Low | $0.88 |
| Volume | 142,289 |
Stock Information
| Shares Outstanding | 3.69M |
| Total Debt | $290K |
| Cash Equivalents | $3.72M |
| Revenue | $735K |
| Net Income | $-10.03M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $3.50M |
| P/E Ratio | 0.00 |
| EPS (TTM) | $1377.40 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-2.34M |
| Sales | $735K |
| Income | $-10.03M |
| Book/sh | $42.63 |
| Cash/sh | $1.01 |
| Employees | 2 |
Financial Ratios
| Quick Ratio | 1.25 |
| Current Ratio | 1.41 |
| Debt/Eq | 2.47 |
Returns & Margins
| ROA | -25.23% |
| ROE | -123.28% |
| Gross Margin | 79.63% |
| Operating Margin | -9748.80% |
Ownership
| Insider Ownership | 0.19% |
| Institutional Ownership | 0.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.12 |
| P/S | 4.76 |
| P/B | 0.02 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.08 |
| SMA50 | $3.84 |
| SMA200 | $75.72 |
| RSI | 34.77 |
| ATR | 0.1039 |
| Shares Float | 1.15M |
| Short Float | 4.53% |
| Short Ratio | 0.04 |
| Volatility | 2.72 |
| Rel Volume | 0.17 |
Performance History
| Week | -6.96% |
| Month | -13.73% |
| Quarter | -96.94% |
| 6 Months | -99.01% |
| YTD | -98.82% |
| Year | -99.53% |
| 3 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $0.95 | 143,800 |
| 2026-06-18 | $0.94 | 471,700 |
| 2026-06-17 | $1.00 | 2,590,400 |
| 2026-06-16 | $1.08 | 4,063,900 |
| 2026-06-15 | $1.09 | 440,500 |
| 2026-06-12 | $1.02 | 394,800 |
| 2026-06-11 | $1.09 | 488,300 |
| 2026-06-10 | $1.05 | 330,200 |
| 2026-06-09 | $0.95 | 329,900 |
| 2026-06-08 | $1.01 | 306,300 |
| 2026-06-05 | $1.03 | 529,000 |
| 2026-06-04 | $1.04 | 270,900 |
| 2026-06-03 | $1.09 | 339,900 |
| 2026-06-02 | $1.14 | 294,400 |
| 2026-06-01 | $1.14 | 432,800 |
| 2026-05-29 | $1.20 | 682,200 |
| 2026-05-28 | $1.17 | 620,100 |
| 2026-05-27 | $1.17 | 736,400 |
| 2026-05-26 | $1.26 | 973,900 |
About Onconetix, Inc.
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
đ° Latest News
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $182,458 | $1,469,018 | $1,185,630 | $0 |
| Cost Of Revenue | $182,458 | $1,469,018 | $1,185,630 | $0 |
| Total Revenue | $815,371 | $2,524,116 | $58,465 | $0 |
| Operating Revenue | $815,371 | $2,524,116 | $58,465 | $0 |
| Expenses | ||||
| Interest Expense | $751,005 | $1,407,678 | $671,625 | $0 |
| Total Expenses | $7,160,227 | $12,855,359 | $17,905,714 | $13,481,240 |
| Other Income Expense | $-6,935,958 | $-47,997,300 | $-18,903,413 | $61,410 |
| Other Non Operating Income Expenses | $3,157,759 | $-3,090,254 | $-134,100 | - |
| Net Non Operating Interest Income Expense | $-751,003 | $-1,407,660 | $-671,625 | $0 |
| Interest Expense Non Operating | $751,005 | $1,407,678 | $671,625 | $0 |
| Operating Expense | $6,977,769 | $11,386,341 | $16,720,084 | $13,481,240 |
| General And Administrative Expense | $7,043,902 | $11,231,982 | $14,770,678 | $9,351,552 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-14,032,342 | $-58,691,023 | $-37,409,694 | $-13,419,830 |
| Net Interest Income | $-751,003 | $-1,407,660 | $-671,625 | $0 |
| Interest Income | $2 | $18 | $0 | - |
| Normalized Income | $-6,058,306 | $-14,569,850 | $-18,646,697 | $-13,481,240 |
| Net Income From Continuing And Discontinued Operation | $-14,032,342 | $-58,691,023 | $-37,409,694 | $-13,419,830 |
| Total Operating Income As Reported | $-17,856,856 | $-56,488,755 | $-36,034,595 | $-13,481,240 |
| Net Income Common Stockholders | $-15,530,937 | $-58,897,427 | $-37,409,694 | $-13,516,189 |
| Net Income | $-14,032,342 | $-58,691,023 | $-37,409,694 | $-13,419,830 |
| Net Income Including Noncontrolling Interests | $-14,032,342 | $-58,691,023 | $-37,409,694 | $-13,419,830 |
| Net Income Continuous Operations | $-14,032,342 | $-58,691,023 | $-37,409,694 | $-13,419,830 |
| Pretax Income | $-14,031,817 | $-59,736,203 | $-37,422,287 | $-13,419,830 |
| Special Income Charges | $-15,952,025 | $-46,157,512 | $-18,677,346 | $0 |
| Interest Income Non Operating | $2 | $18 | $0 | - |
| Operating Income | $-6,344,856 | $-10,331,243 | $-17,847,249 | $-13,481,240 |
| Gross Profit | $632,913 | $1,055,098 | $-1,127,165 | $0 |
| Per Share | ||||
| Diluted EPS | $-828.00 | $-21301.06 | $-285570.18 | $-151867.29 |
| Basic EPS | $-828.00 | $-21301.06 | $-285570.18 | $-151867.29 |
| Other | ||||
| Tax Effect Of Unusual Items | $-2,119,681 | $-785,873 | $-6,316 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,171,925 | $-12,690,134 | $-17,937,412 | $-13,474,488 |
| Total Unusual Items | $-10,093,717 | $-44,907,046 | $-18,769,313 | $61,410 |
| Total Unusual Items Excluding Goodwill | $-10,093,717 | $-44,907,046 | $-18,769,313 | $61,410 |
| Reconciled Depreciation | $15,170 | $731,345 | $43,937 | $6,752 |
| EBITDA (Bullshit earnings) | $-13,265,642 | $-57,597,180 | $-36,706,725 | $-13,413,078 |
| EBIT | $-13,280,812 | $-58,328,525 | $-36,750,662 | $-13,419,830 |
| Diluted Average Shares | $18,753 | $2,765 | $131 | $89 |
| Basic Average Shares | $18,753 | $2,765 | $131 | $89 |
| Diluted NI Availto Com Stockholders | $-15,530,937 | $-58,897,427 | $-37,409,694 | $-13,516,189 |
| Preferred Stock Dividends | $1,498,595 | $206,404 | - | $96,359 |
| Tax Provision | $525 | $-1,045,180 | $-12,593 | $0 |
| Other Special Charges | $4,440,025 | - | $490,000 | - |
| Write Off | $0 | $3,530,716 | $18,187,346 | $0 |
| Impairment Of Capital Assets | $11,512,000 | $42,626,796 | $0 | - |
| Gain On Sale Of Security | $5,858,308 | $1,250,466 | $-91,967 | $61,410 |
| Research And Development | $-66,133 | $154,359 | $1,949,406 | $4,129,688 |
| Selling General And Administration | $7,043,902 | $11,231,982 | $14,770,678 | $9,351,552 |
| Other Gand A | $7,043,902 | $11,231,982 | $14,770,678 | $9,351,552 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-2,782,654 | $-17,438,418 | $-86,689,057 | $22,388,002 |
| Total Assets | $24,926,638 | $28,181,563 | $87,518,032 | $26,310,447 |
| Total Non Current Assets | $18,859,864 | $27,231,296 | $81,679,761 | $52,706 |
| Non Current Deferred Assets | $225,000 | $0 | $366,113 | $0 |
| Goodwill And Other Intangible Assets | $18,549,005 | $27,048,973 | $81,087,029 | $0 |
| Current Assets | $6,066,774 | $950,267 | $5,838,271 | $26,257,741 |
| Prepaid Assets | $307,291 | $143,380 | $770,153 | $469,232 |
| Inventory | $149,961 | $64,079 | $364,052 | $0 |
| Receivables | $388,868 | $96,308 | $149,731 | $35,850 |
| Other Receivables | $60,047 | $41,835 | - | - |
| Taxes Receivable | $31,955 | $28,756 | $0 | - |
| Accounts Receivable | $296,866 | $25,717 | $149,731 | $0 |
| Cash Cash Equivalents And Short Term Investments | $5,220,654 | $646,500 | $4,554,335 | $25,752,659 |
| Cash And Cash Equivalents | $5,220,654 | $646,500 | $4,554,335 | $25,752,659 |
| Cash Financial | $5,220,654 | $646,500 | $4,554,335 | $25,752,659 |
| Non Current Prepaid Assets | - | $0 | $17,423 | $38,617 |
| Other Intangible Assets | - | - | $25,410,887 | - |
| Current Deferred Assets | - | - | - | $0 |
| Debt | ||||
| Total Debt | $48,774 | $9,447,488 | $9,885,772 | $0 |
| Long Term Debt And Capital Lease Obligation | $24,362 | $0 | $193,147 | $0 |
| Current Debt And Capital Lease Obligation | $24,412 | $9,447,488 | $9,692,625 | - |
| Net Debt | - | $8,681,561 | $5,182,895 | - |
| Current Debt | - | $9,328,061 | $9,618,373 | - |
| Other Current Borrowings | - | $9,328,061 | $9,618,373 | - |
| Long Term Debt | - | - | $118,857 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $9,160,287 | $18,571,008 | $86,113,556 | $3,922,445 |
| Total Non Current Liabilities Net Minority Interest | $24,362 | $280,879 | $68,923,309 | $0 |
| Current Liabilities | $9,135,925 | $18,290,129 | $17,190,247 | $3,922,445 |
| Other Current Liabilities | $7,011,937 | $43,089 | $2,641 | $14,021 |
| Current Notes Payable | $0 | $9,328,061 | - | - |
| Payables And Accrued Expenses | $2,057,348 | $8,612,596 | $7,007,402 | $2,775,565 |
| Interest Payable | $0 | $139,409 | $0 | - |
| Payables | $1,837,695 | $7,950,564 | $5,355,644 | $1,676,896 |
| Total Tax Payable | $80,000 | $40,000 | $60,530 | $177,600 |
| Accounts Payable | $1,757,695 | $3,787,564 | $5,295,114 | $1,499,296 |
| Tradeand Other Payables Non Current | - | $0 | $0 | $0 |
| Non Current Deferred Liabilities | - | $0 | $3,073,781 | $0 |
| Non Current Deferred Taxes Liabilities | - | $0 | $3,073,781 | $0 |
| Other Non Current Liabilities | - | - | $864,000 | - |
| Equity | ||||
| Common Stock Equity | $15,764,627 | $8,542,627 | $-5,602,028 | $22,388,002 |
| Preferred Stock Equity | $1,724 | $1,067,928 | - | - |
| Total Equity Gross Minority Interest | $15,766,351 | $9,610,555 | $1,404,476 | $22,388,002 |
| Stockholders Equity | $15,766,351 | $9,610,555 | $-5,602,028 | $22,388,002 |
| Gains Losses Not Affecting Retained Earnings | $-231,028 | $-2,723,397 | $2,380,920 | $0 |
| Other Equity Adjustments | $-231,028 | $-2,723,397 | - | - |
| Retained Earnings | $-131,214,558 | $-115,683,621 | $-56,786,194 | $-19,376,500 |
| Other Equity Interest | - | $-250,308 | - | - |
| Preferred Securities Outside Stock Equity | - | $0 | $64,236,085 | $0 |
| Other | ||||
| Treasury Shares Number | $3 | $3 | $3 | $2 |
| Ordinary Shares Number | $31,200 | $2,765 | $131 | $89 |
| Share Issued | $31,203 | $2,768 | $134 | $91 |
| Tangible Book Value | $-2,784,378 | $-18,506,346 | $-86,689,057 | $22,388,002 |
| Invested Capital | $15,764,627 | $17,870,688 | $4,135,202 | $22,388,002 |
| Working Capital | $-3,069,151 | $-17,339,862 | $-11,351,976 | $22,335,296 |
| Capital Lease Obligations | $48,774 | $119,427 | $148,542 | $0 |
| Total Capitalization | $15,766,351 | $9,610,555 | $-5,483,171 | $22,388,002 |
| Treasury Stock | $625,791 | $625,791 | $625,791 | $566,810 |
| Additional Paid In Capital | $147,835,989 | $127,825,743 | $49,429,031 | $42,331,155 |
| Capital Stock | $1,739 | $1,067,929 | $6 | $157 |
| Common Stock | $15 | $1 | $6 | $157 |
| Preferred Stock | $1,724 | $1,067,928 | $0 | $0 |
| Employee Benefits | $0 | $280,879 | $556,296 | $0 |
| Non Current Pension And Other Postretirement Benefit Plans | $0 | $280,879 | $556,296 | $0 |
| Long Term Capital Lease Obligation | $24,362 | $0 | $74,290 | $0 |
| Current Capital Lease Obligation | $24,412 | $119,427 | $74,252 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $42,228 | $186,956 | $487,579 | $1,132,859 |
| Current Accrued Expenses | $219,653 | $662,032 | $1,651,758 | $1,098,669 |
| Dueto Related Parties Current | $0 | $4,123,000 | $0 | - |
| Goodwill | $18,549,005 | $27,048,973 | $55,676,142 | $0 |
| Net PPE | $85,859 | $182,323 | $209,196 | $14,089 |
| Gross PPE | $85,859 | $182,323 | $209,196 | $14,089 |
| Other Properties | $85,859 | $182,323 | $209,196 | $14,089 |
| Finished Goods | $46,530 | $6,633 | $30,039 | $0 |
| Raw Materials | $103,431 | $57,446 | $139,208 | $0 |
| Minority Interest | - | $0 | $7,006,504 | $0 |
| Dueto Related Parties Non Current | - | $0 | $864,000 | $0 |
| Work In Process | - | $0 | $194,805 | $0 |
| Duefrom Related Parties Current | - | - | $0 | $35,850 |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,678,390 | $-10,524,287 | $-13,636,062 | $-8,684,873 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,678,390 | $-10,495,816 | $-13,581,018 | $-8,675,534 |
| Cash Flow From Continuing Operating Activities | $-9,678,390 | $-10,495,816 | $-13,581,018 | $-8,675,534 |
| Operating Gains Losses | $-1,075,705 | $-1,298,889 | $595,842 | $-61,410 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $-28,471 | $-8,649,035 | $-32,665 |
| Cash Flow From Continuing Investing Activities | $0 | $-28,471 | $-8,649,035 | $-32,665 |
| Capital Expenditure | - | $-28,471 | $-55,044 | $-9,339 |
| Net Other Investing Changes | - | - | $-9,650,569 | $-23,326 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-1,714,496 | $-718 | $-58,981 | $-566,810 |
| Issuance Of Capital Stock | $21,942,855 | $3,483,031 | $2,298,675 | $34,868,123 |
| Financing Cash Flow | $14,452,686 | $6,743,110 | $1,035,060 | $32,532,384 |
| Cash Flow From Continuing Financing Activities | $14,452,686 | $6,743,110 | $1,035,060 | $32,532,384 |
| Net Preferred Stock Issuance | $13,837,630 | $2,797,749 | $2,298,675 | $0 |
| Preferred Stock Issuance | $15,551,200 | $2,797,749 | $2,298,675 | $0 |
| Net Common Stock Issuance | $6,390,729 | $684,564 | $-58,981 | $34,301,313 |
| Common Stock Issuance | $6,391,655 | $685,282 | $0 | $34,868,123 |
| Net Other Financing Charges | - | $-400,000 | $-205,093 | $-1,772,020 |
| Other | ||||
| Repayment Of Debt | $-7,111,548 | $-1,345,521 | $-1,000,000 | $0 |
| Issuance Of Debt | $1,335,875 | $5,000,000 | $0 | - |
| Interest Paid Supplemental Data | $766,330 | $379,409 | $0 | - |
| End Cash Position | $5,220,654 | $646,500 | $4,554,335 | $25,752,659 |
| Beginning Cash Position | $646,500 | $4,554,335 | $25,752,659 | $1,928,474 |
| Effect Of Exchange Rate Changes | $-200,142 | $-126,658 | $-3,331 | $0 |
| Changes In Cash | $4,774,296 | $-3,781,177 | $-21,194,993 | $23,824,185 |
| Proceeds From Stock Option Exercised | $0 | $6,318 | $459 | $3,091 |
| Preferred Stock Payments | $-1,713,570 | $0 | - | - |
| Common Stock Payments | $-926 | $-718 | $-58,981 | $-566,810 |
| Net Issuance Payments Of Debt | $-5,775,673 | $3,654,479 | $-1,000,000 | $0 |
| Net Long Term Debt Issuance | $-5,775,673 | $3,654,479 | $-1,000,000 | $0 |
| Long Term Debt Payments | $-7,111,548 | $-1,345,521 | $-1,000,000 | $0 |
| Long Term Debt Issuance | $1,335,875 | $5,000,000 | $0 | - |
| Net PPE Purchase And Sale | $0 | $-28,471 | $-55,044 | $-9,339 |
| Purchase Of PPE | $0 | $-28,471 | $-55,044 | $-9,339 |
| Change In Working Capital | $-2,419,452 | $-1,541,362 | $1,622,975 | $2,560,464 |
| Change In Other Working Capital | $-225,000 | - | - | - |
| Change In Other Current Assets | $0 | $-7,749 | $-16,883 | $-38,617 |
| Change In Payables And Accrued Expense | $-1,673,687 | $-2,606,125 | $2,430,573 | $2,833,762 |
| Change In Accrued Expense | $-580,032 | $-1,129,050 | $-942,075 | $1,739,849 |
| Change In Payable | $-1,093,655 | $-1,477,075 | $3,372,648 | $1,093,913 |
| Change In Account Payable | $-1,093,655 | $-1,477,075 | $3,372,648 | $1,093,913 |
| Change In Prepaid Assets | $-128,360 | $1,018,109 | $-412,601 | $-234,681 |
| Change In Inventory | $-73,720 | $-62,273 | $-315,828 | $0 |
| Change In Receivables | $-318,685 | $116,676 | $-62,286 | $0 |
| Changes In Account Receivables | $-268,685 | $116,676 | $-62,286 | $0 |
| Other Non Cash Items | $-3,752,328 | $4,396,491 | $1,642,021 | $263,924 |
| Stock Based Compensation | $74,267 | $438,653 | $329,760 | $1,974,566 |
| Asset Impairment Charge | $11,512,000 | $46,514,150 | $18,454,365 | $0 |
| Deferred Tax | $0 | $-1,045,181 | $-12,593 | $0 |
| Deferred Income Tax | $0 | $-1,045,181 | $-12,593 | $0 |
| Depreciation Amortization Depletion | $15,170 | $731,345 | $43,937 | $6,752 |
| Depreciation And Amortization | $15,170 | $731,345 | $43,937 | $6,752 |
| Pension And Employee Benefit Expense | $-619,399 | $-48,423 | $13,875 | $0 |
| Gain Loss On Investment Securities | $-5,858,308 | $-1,250,466 | $91,967 | $-61,410 |
| Gain Loss On Sale Of PPE | $17,283 | $0 | - | $0 |
| Net Income From Continuing Operations | $-14,032,342 | $-58,691,023 | $-37,409,694 | $-13,419,830 |
| Net Business Purchase And Sale | - | $0 | $1,056,578 | $0 |
| Sale Of Business | - | $0 | $1,056,578 | $0 |
| Provisionand Write Offof Assets | - | $0 | $1,152,369 | - |
| Depreciation | - | - | - | $6,752 |
Fetched: 2026-06-23